Table 7.
Characteristics of patients alive and in remission.
| Patient | Age at alloHSCT | Primary Disease at alloHSCT | Disease Status at alloHSCT | Blasts in PB* | Blasts in BM* | Duval Score | aGVHD Max Grade | cGVHD Max Grade | Days from alloHSCT to Last Contact |
|---|---|---|---|---|---|---|---|---|---|
| 01 | 34.4 | Biphenotypic leukemia |
Induction failure |
0% | 1% | N/A | None | None | 2190 |
| 02 | 22.4 | AML | Induction failure |
0% | 2% | 1 | None | None | 850 |
| 03 | 31.3 | ALL, Ph+ | Induction failure |
0% | 50% | 3 | III | Extensive | 1803 |
| 04 | 49.2 | AML | Induction failure |
0% | 42% | 1 | None | Extensive | 1457 |
| 05 | 47.6 | ALL | Induction failure |
N/A | 25% | 4 | II | Extensive | 735 |
| 06 | 50.2 | AML | 1st relapse |
0% | 5% | 1 | II | None | 362 |
| 07 | 56.5 | AML | Induction failure |
16% | 70% | 3 | II | Extensive | 762 |
| 08 | 53.8 | AML | Induction failure |
N/A | 10% | 1 | None | Extensive | 715 |
| 09 | 34.3 | AML | Induction failure |
30% | 80% | 3 | II | Extensive | 761 |
| 10 | 16.5 | ALL | Induction failure |
49% | 95% | 3 | II | Extensive | 392 |
| 11 | 40.5 | AML | Induction failure |
5% | 20% | 4 | I | None | 104 |
| 12 | 21.2 | Undifferentiated leukemia |
Induction failure |
2% | 30% | N/A | II | None | 100 |
AML=acute myeloid leukemia, ALL=acute lymphoblastic leukemia, BM = bone marrow, N/A = not available, PB = peripheral blood, Ph=Philadelphia chromosome.
*
At time of transplant.